Home>Topics>>NPS Pharmaceuticals' CEO Discusses Gattex Update (Transcript)
NPS Pharmaceuticals' CEO Discusses Gattex Update (Transcript)
Healthcare Sector and Stocks Analysis from Seeking Alpha
Wed, 17 Oct 2012
NPS Pharmaceuticals, Inc. ( NPSP ) Special Call October 17, 2012 8:30 a.m. ET Executives Susan Mesco - Senior Director, IR and Corporate Communications Francois Nader - President and Chief Executive Officer Analysts Salveen Richter - Canaccord Genuity Eun Yang - Jefferies Joseph Schwartz - Leerink ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.